Robert Winebrenner is an associate equity analyst, healthcare, for Morningstar. He assists in supporting analysts' coverage for medical-device and biotechnology stocks.
Before joining Morningstar in 2023, Winebrenner interned for U.S. Bank's global fund services department. He worked with Morningstar Direct's product support team before moving to equity research.
Winebrenner holds a bachelor’s degree in finance from Miami University’s Farmer School of Business. He is a Level II candidate in the Chartered Financial Analyst® program.